Visteon Corporation (VC) Cash Flow Statement

The ratio of operating cash flow to net income has been erratic for ten quarters, swinging from 7.60 in 2026Q3 (on a trivial $5M net income base) down to 0.19 in 2026Q1. This volatility, particularly the 2026Q1 near-zero conversion where $31M of net income produced only $6M of operating cash flow, suggests that earnings are increasingly supported by accruals rather than cash collections. When read alongside the 4.8% gross margin trough documented in the income statement analysis, the operating cash flow compression implies the margin erosion is genuine and not a timing artifact — it is bleeding through to the cash statement.

The FCF margin trajectory tells the story starkly: 17.3% in 2024Q4 collapsed to -0.4% in 2026Q3, with intermediate quarters of -3.1% and 1.2%. This is not a gradual decline but an abrupt regime shift, consistent with the gross margin compression and revenue stagnation identified in the prior income statement work. Critically, this deterioration occurred even as capital expenditures remained within a relatively tight range ($22M–$45M quarterly), meaning the FCF deficit is driven by operating cash flow decay rather than a capital investment surge — a more concerning pattern for sustainability.

The working capital drag escalated sharply from -$6M in 2025Q4 to -$53M in 2026Q2 and -$66M in 2026Q1, before moderating to -$7M in 2026Q3. While the recent moderation could suggest inventory correction or tightened collections, the cumulative four-quarter drain of $133M represents a material drag that compounds the operating cash flow shortfall. Given Visteon's project-based revenue model tied to multi-year OEM program lifecycles, this working capital consumption may reflect the inventory positioning required for new program launches, though investors should monitor whether it normalizes or persists as a structural cash requirement.

The $200M buyback in 2026Q3 is an order of magnitude larger than any prior quarter in the dataset and occurred simultaneously with negative FCF and a $5M net income result. This suggests management is deliberately returning capital during a trough, which could be value-accretive if the earnings weakness proves cyclical, or value-destructive if the margin compression proves structural. The prior statement analysis flagged that the 2026Q3 gross margin of 4.8% may signal competitive deterioration rather than temporary disruption; if so, deploying cash reserves to buy back stock at a time when operating fundamentals are deteriorating warrants close scrutiny from a capital allocation standpoint.